Compass Therapeutics, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:CMPX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 131.45 M116.7 M231.26 M219.59 M205.17 M Total liabilities 21.17 M23.49 M21.65 M22.8 M18.7 M Total equity 110.28 M93.21 M209.61 M196.79 M186.47 M Total liabilities & shareholders' equities 131.45 M116.7 M231.26 M219.59 M205.17 M Total debt ————— Net debt —————

News

Wall Street Lunch: AI Chipmaker Seeks $3.5B In IPO, Eyes $26.5B Valuation

Compass Therapeutics, Inc. (CMPX) Discusses Positive Secondary Endpoint Results From COMPANION-002 Study in Advanced Biliary Tract Cancer Transcript

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.13%

Nike Stock Options Alert: LEAPS Buying Hints at a Bull Call Spread

Will Psychedelic Stocks Have A Trippy Ride Under RFK Jr.?

Compass Therapeutics stock rating reaffirmed at Citizens on trial progress

Jefferies raises Compass Therapeutics stock price target on trial progress

Compass Therapeutics stock holds Outperform at William Blair ahead of trial data

Raymond James reiterates Compass Therapeutics stock Outperform rating

Compass Therapeutics earnings on deck as pivotal cancer data looms

Is Compass Therapeutics, Inc. (CMPX) Outperforming Other Medical Stocks This Year?

Craig-Hallum initiates coverage on Compass Therapeutics stock with Buy rating